Organogenesis (ORGO)
(Delayed Data from NSDQ)
$2.55 USD
-0.07 (-2.67%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $2.56 +0.01 (0.39%) 7:58 PM ET
5-Strong Sell of 5 5
B Value F Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $0.01 | 0.00% |
Earnings Summary
For their last quarter, Organogenesis (ORGO) reported earnings of -$0.13 per share, missing the Zacks Consensus Estimate of -$0.02 per share. This reflects a negative earnings surprise of 550.00%. Look out for ORGO's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of $0.01 per share, reflecting a year-over-year decrease of 50%.
Earnings History
Price & Consensus
Zacks News for ORGO
Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Tops Revenue Estimates
ORGO: What are Zacks experts saying now?
Zacks Private Portfolio Services